Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL4397256

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Binding
Inhibition of recombinant human His6-tagged PDE4D UCR2 deletion mutant catalytic domain expressed in baculovirus infected Sf9 insect cells using cAMP as substrate preincubated for 5 to 10 mins followed by substrate addition and measured for 10 mins by yeast myokinase/pyruvate kinase/lactate dehydrogenase-coupled fluorescence assay
3
Total Activities
3
Compounds Tested
1
Activity Types
0
Assay Parameters

Assay Information

Assay Type Binding
Organism Homo sapiens
Cell Type Sf9
Confidence 0 — Uncurated / Unknown
Curated By Autocuration

Target

Unchecked (CHEMBL612545)
Type UNCHECKED

Publication

Design and Synthesis of Selective Phosphodiesterase 4D (PDE4D) Allosteric Inhibitors for the Treatment of Fragile X Syndrome and Other Brain Disorders.
Gurney ME, Nugent RA, Mo X, Sindac JA, Hagen TJ, Fox D, O'Donnell JM, Zhang C, Xu Y, Zhang HT, Groppi VE, Bailie M, White RE, Romero DL, Vellekoop AS, Walker JR, Surman MD, Zhu L, Campbell RF.
J Med Chem (2019) 62 : 4884 -4901
PubMed 31013090 · DOI

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
IC50 3 6.43 7.68

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL514800 APREMILAST 4.0 1 7.68
CHEMBL4541964 ZATOLMILAST 3.0 1 5.18
CHEMBL4593524 1 -

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL514800 APREMILAST IC50 = 21.0 nM 7.68
CHEMBL4541964 ZATOLMILAST IC50 = 6561.0 nM 5.18
CHEMBL4593524 IC50 - -